Aeglea BioTherapeutics, Inc.
SEC Filing List
AGLE CIK: 0001636282
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Turtle Cameron | Spyre Therapeutics, Inc. | 07/02/2026 | |
| 4 | Statement of changes in beneficial owner... | Burrows Scott L | Spyre Therapeutics, Inc. | 07/02/2026 | |
| 4 | Statement of changes in beneficial owner... | Sloan Sheldon | Spyre Therapeutics, Inc. | 07/02/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 07/01/2026 | ||
| S-3ASR | Automatic shelf registration statement o... | Spyre Therapeutics, Inc. | Workiva Inc. Wdesk FA01 /fa | 06/26/2026 | |
| 4 | Statement of changes in beneficial owner... | Burrows Scott L | Spyre Therapeutics, Inc. | 06/26/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 06/25/2026 | ||
| 4 | Statement of changes in beneficial owner... | Toppan Merrill/FA | 06/23/2026 | ||
| SCHEDULE 13D/A | Toppan Merrill/FA | 06/23/2026 | |||
| 4 | Statement of changes in beneficial owner... | Henderson Michael Thomas | Spyre Therapeutics, Inc. | 06/23/2026 | |
| No record found. | |||||
| Load More | |||||